vs

Side-by-side financial comparison of COLONY BANKCORP INC (CBAN) and GRAIL, Inc. (GRAL). Click either name above to swap in a different company.

GRAIL, Inc. is the larger business by last-quarter revenue ($43.6M vs $39.9M, roughly 1.1× COLONY BANKCORP INC). COLONY BANKCORP INC runs the higher net margin — 20.6% vs -227.5%, a 248.0% gap on every dollar of revenue. Over the past eight quarters, GRAIL, Inc.'s revenue compounded faster (27.7% CAGR vs 19.6%).

Colony Bankcorp Inc is a US-based bank holding company that operates Colony Bank. It provides a full suite of personal and commercial banking services including deposit accounts, consumer and business loans, mortgage services, and wealth management solutions, primarily serving retail customers and small-to-medium enterprises across the state of Georgia.

GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.

CBAN vs GRAL — Head-to-Head

Bigger by revenue
GRAL
GRAL
1.1× larger
GRAL
$43.6M
$39.9M
CBAN
Higher net margin
CBAN
CBAN
248.0% more per $
CBAN
20.6%
-227.5%
GRAL
Faster 2-yr revenue CAGR
GRAL
GRAL
Annualised
GRAL
27.7%
19.6%
CBAN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CBAN
CBAN
GRAL
GRAL
Revenue
$39.9M
$43.6M
Net Profit
$8.2M
$-99.2M
Gross Margin
Operating Margin
-285.4%
Net Margin
20.6%
-227.5%
Revenue YoY
14.0%
Net Profit YoY
24.1%
-2.2%
EPS (diluted)
$-2.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBAN
CBAN
GRAL
GRAL
Q1 26
$39.9M
Q4 25
$36.9M
$43.6M
Q3 25
$32.8M
$36.2M
Q2 25
$32.5M
$35.5M
Q1 25
$30.0M
$31.8M
Q4 24
$30.8M
$38.3M
Q3 24
$28.6M
$28.7M
Q2 24
$27.9M
$32.0M
Net Profit
CBAN
CBAN
GRAL
GRAL
Q1 26
$8.2M
Q4 25
$-99.2M
Q3 25
$5.8M
$-89.0M
Q2 25
$8.0M
$-114.0M
Q1 25
$6.6M
$-106.2M
Q4 24
$-97.1M
Q3 24
$5.6M
$-125.7M
Q2 24
$5.5M
$-1.6B
Operating Margin
CBAN
CBAN
GRAL
GRAL
Q1 26
Q4 25
25.9%
-285.4%
Q3 25
22.2%
-346.2%
Q2 25
30.9%
-446.9%
Q1 25
27.6%
-482.5%
Q4 24
28.8%
-358.0%
Q3 24
24.6%
-640.5%
Q2 24
24.8%
-5133.8%
Net Margin
CBAN
CBAN
GRAL
GRAL
Q1 26
20.6%
Q4 25
-227.5%
Q3 25
17.7%
-245.8%
Q2 25
24.6%
-320.7%
Q1 25
22.0%
-333.6%
Q4 24
-253.8%
Q3 24
19.7%
-438.7%
Q2 24
19.6%
-4958.8%
EPS (diluted)
CBAN
CBAN
GRAL
GRAL
Q1 26
Q4 25
$0.42
$-2.37
Q3 25
$0.33
$-2.46
Q2 25
$0.46
$-3.18
Q1 25
$0.38
$-3.10
Q4 24
$0.43
$-1.49
Q3 24
$0.32
$-3.94
Q2 24
$0.31
$-51.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBAN
CBAN
GRAL
GRAL
Cash + ST InvestmentsLiquidity on hand
$295.8M
$249.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$380.4M
$2.6B
Total Assets
$3.7B
$2.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBAN
CBAN
GRAL
GRAL
Q1 26
$295.8M
Q4 25
$249.7M
Q3 25
$126.9M
Q2 25
$127.4M
Q1 25
$133.9M
Q4 24
$214.2M
Q3 24
$853.6M
Q2 24
$958.8M
Total Debt
CBAN
CBAN
GRAL
GRAL
Q1 26
Q4 25
$258.1M
Q3 25
Q2 25
Q1 25
Q4 24
$248.0M
Q3 24
Q2 24
Stockholders' Equity
CBAN
CBAN
GRAL
GRAL
Q1 26
$380.4M
Q4 25
$375.9M
$2.6B
Q3 25
$302.3M
$2.2B
Q2 25
$293.9M
$2.3B
Q1 25
$286.9M
$2.4B
Q4 24
$278.7M
$2.5B
Q3 24
$276.1M
$2.6B
Q2 24
$264.7M
$2.7B
Total Assets
CBAN
CBAN
GRAL
GRAL
Q1 26
$3.7B
Q4 25
$3.7B
$2.9B
Q3 25
$3.2B
$2.6B
Q2 25
$3.1B
$2.7B
Q1 25
$3.2B
$2.8B
Q4 24
$3.1B
$3.0B
Q3 24
$3.1B
$3.1B
Q2 24
$3.0B
$3.3B
Debt / Equity
CBAN
CBAN
GRAL
GRAL
Q1 26
Q4 25
0.69×
Q3 25
Q2 25
Q1 25
Q4 24
0.89×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBAN
CBAN
GRAL
GRAL
Operating Cash FlowLast quarter
$-63.8M
Free Cash FlowOCF − Capex
$-63.9M
FCF MarginFCF / Revenue
-146.5%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-299.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBAN
CBAN
GRAL
GRAL
Q1 26
Q4 25
$-5.5M
$-63.8M
Q3 25
$14.4M
$-63.2M
Q2 25
$15.8M
$-77.0M
Q1 25
$17.9M
$-95.0M
Q4 24
$23.4M
Q3 24
$20.5M
$-104.6M
Q2 24
$1.1M
$-171.8M
Free Cash Flow
CBAN
CBAN
GRAL
GRAL
Q1 26
Q4 25
$-6.9M
$-63.9M
Q3 25
$14.1M
$-63.6M
Q2 25
$15.8M
$-77.3M
Q1 25
$17.6M
$-95.1M
Q4 24
$22.3M
Q3 24
$20.2M
$-105.6M
Q2 24
$990.0K
$-173.2M
FCF Margin
CBAN
CBAN
GRAL
GRAL
Q1 26
Q4 25
-18.7%
-146.5%
Q3 25
42.9%
-175.8%
Q2 25
48.5%
-217.6%
Q1 25
58.7%
-298.6%
Q4 24
72.5%
Q3 24
70.6%
-368.4%
Q2 24
3.5%
-541.7%
Capex Intensity
CBAN
CBAN
GRAL
GRAL
Q1 26
Q4 25
3.7%
0.2%
Q3 25
1.1%
1.1%
Q2 25
0.3%
1.0%
Q1 25
1.2%
0.2%
Q4 24
3.5%
Q3 24
1.0%
3.4%
Q2 24
0.5%
4.3%
Cash Conversion
CBAN
CBAN
GRAL
GRAL
Q1 26
Q4 25
Q3 25
2.48×
Q2 25
1.99×
Q1 25
2.71×
Q4 24
Q3 24
3.64×
Q2 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBAN
CBAN

Net Interest Income$29.2M73%
Noninterest Income$10.7M27%

GRAL
GRAL

Screening Revenue$42.3M97%
Developmental Services Revenue$1.3M3%

Related Comparisons